Evidence map›Paper›PMID 32275784›Full record

ArticleHepatology (Baltimore, Md.)2020

Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action?

Marina Serper, Allen W Cubell, Mary Elisabeth Deleener, Tara K Casher, Dale J Rosenberg, Dale Whitebloom, Roy M Rosin

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 6 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 6 syntheses or guidelines pooled it, 140 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Guideline
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Telemedicine in the tertiary liver unit: A feasibility study.Clinical and experimental hepatology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. High Satisfaction with Patient-Centered Telemedicine for Hepatitis C Virus Delivered to Substance Users: A Mixed-Methods Study.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2023
    Article
  19. Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Marina SerperDivision of Gastroenterology and Hepatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.ORCID 0000-0003-4899-2160
Allen W CubellPenn Medicine, Lancaster General Health, Lancaster, PA.
Mary Elisabeth DeleenerPenn Medicine, University of Pennsylvania Health System, Philadelphia, PA.
Tara K CasherPenn Medicine, Lancaster General Health, Lancaster, PA.
Dale J RosenbergUS Digestive Health, Lancaster, PA.
Dale WhitebloomUS Digestive Health, Lancaster, PA.
Roy M RosinLeonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA.
Lancaster General Hospital · USUniversity of Pennsylvania Health System · USUniversity of Pennsylvania · US

Funding

Developing technology-based approaches to improve access and quality of care in cirrhosisK23DK115897 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI SERPER, MARINA · 2018 to 2022
$961k
NIDDK NIH HHS 1K23DK115897-02NIDDK NIH HHS K23 DK115897
6 · The paper itself

Abstract

Evidence strongly supports that access to specialty gastroenterology or hepatology care in cirrhosis is associated with higher adherence to guideline-recommended care and improves clinical outcomes. Presently, only about one half of acute care hospitalizations for cirrhosis-related complications result in inpatient specialty care, and the current hepatology workforce cannot meet the demand of patients with liver disease nationwide, particularly in less densely populated areas and in community-based practices not affiliated with academic centers. Telemedicine, defined as the delivery of health care services at a distance using electronic means for diagnosis and treatment, holds tremendous promise to increase access to broadly specialty care. The technology is cheap and easy to use, although it is presently limited in scale by interstate licensing restrictions and reimbursement barriers. The outbreak of severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 has, in the short term, accelerated the growth of telemedicine delivery as a public health and social distancing measure. Herein, we examine whether this public health crisis can accelerate the national conversation about broader adoption of telemedicine for routine medical care in non-crisis situations, using a case series from our telehepatology program as a pragmatic example.

Indexed as

BetacoronavirusTelemedicineAdultAgedCoronavirus InfectionsCOVID-19EmergenciesFemaleHumansLiver DiseasesMaleMiddle AgedPandemicsPatient Acceptance of Health CarePilot ProjectsPneumonia, Viral

Identifiers

PMID32275784
PMCPMC7262294
OpenAlexW3015421112

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.